Display options
Cite
Kling C, Pulliainen AT, Barth H, et al. Human Peptides α-Defensin-1 and -5 Inhibit Pertussis Toxin. Toxins (Basel). 2021;13(7)doi: 10.3390/toxins13070480.
Kling, C., Pulliainen, A. T., Barth, H., & Ernst, K. (2021). Human Peptides α-Defensin-1 and -5 Inhibit Pertussis Toxin. Toxins, 13(7), . https://doi.org/10.3390/toxins13070480
Kling, Carolin, et al. "Human Peptides α-Defensin-1 and -5 Inhibit Pertussis Toxin." Toxins vol. 13,7 (2021). doi: https://doi.org/10.3390/toxins13070480
Kling C, Pulliainen AT, Barth H, Ernst K. Human Peptides α-Defensin-1 and -5 Inhibit Pertussis Toxin. Toxins (Basel). 2021 Jul 11;13(7). doi: 10.3390/toxins13070480. PMID: 34357952; PMCID: PMC8310310.
Copy Download .nbib Format: NLM
Share it on

Toxins (Basel). 2021 Jul 11;13(7). doi: 10.3390/toxins13070480.

Human Peptides α-Defensin-1 and -5 Inhibit Pertussis Toxin.

Toxins

Carolin Kling, Arto T Pulliainen, Holger Barth, Katharina Ernst

Affiliations

  1. Institute of Pharmacology and Toxicology, Ulm University Medical Center, 89081 Ulm, Germany.
  2. Institute of Biomedicine, Research Unit for Infection and Immunity, University of Turku, FI-20520 Turku, Finland.

PMID: 34357952 PMCID: PMC8310310 DOI: 10.3390/toxins13070480

[No abstract available.]

Keywords: ADP-ribosylating toxin; antimicrobial peptide; bacterial AB-type toxin; defensins; human peptide; pertussis toxin; toxin inhibitor

References

  1. Biochemistry. 1982 Oct 26;21(22):5516-22 - PubMed
  2. FEBS J. 2011 Oct;278(20):3942-51 - PubMed
  3. Structure. 1994 Jan 15;2(1):45-57 - PubMed
  4. J Immunol. 1995 Apr 15;154(8):4157-65 - PubMed
  5. Pathog Dis. 2016 Aug;74(6): - PubMed
  6. Biochemistry. 1997 Sep 16;36(37):11051-4 - PubMed
  7. Infect Immun. 2012 Dec;80(12):4317-32 - PubMed
  8. Immunity. 2014 Nov 20;41(5):709-21 - PubMed
  9. Gastroenterology. 2008 Jun;134(7):2049-58 - PubMed
  10. Front Pharmacol. 2020 Aug 12;11:1204 - PubMed
  11. Lancet Infect Dis. 2017 Sep;17(9):974-980 - PubMed
  12. Biochem J. 2006 Oct 15;399(2):225-9 - PubMed
  13. Biochemistry. 2006 Nov 21;45(46):13734-40 - PubMed
  14. Trends Microbiol. 2006 Oct;14(10):428-31 - PubMed
  15. Infect Immun. 2008 Nov;76(11):5139-48 - PubMed
  16. Pediatr Infect Dis. 1984 Sep-Oct;3(5):467-86 - PubMed
  17. Cell. 1989 Mar 10;56(5):801-13 - PubMed
  18. J Biol Chem. 1992 Nov 15;267(32):23216-25 - PubMed
  19. J Mol Biol. 1996 May 17;258(4):661-71 - PubMed
  20. Infect Immun. 2016 Nov 18;84(12):3388-3398 - PubMed
  21. Toxins (Basel). 2018 May 01;10(5): - PubMed
  22. J Immunol. 1985 Dec;135(6):4135-43 - PubMed
  23. ACS Sens. 2020 Nov 25;5(11):3438-3448 - PubMed
  24. Infect Immun. 2007 Jun;75(6):2946-53 - PubMed
  25. Biol Chem. 2017 Sep 26;398(10):1069-1085 - PubMed
  26. J Biol Chem. 1988 Jun 25;263(18):8677-84 - PubMed
  27. FASEB J. 2020 May;34(5):6244-6261 - PubMed
  28. Clin Microbiol Rev. 2005 Apr;18(2):326-82 - PubMed
  29. Infect Immun. 1993 Jan;61(1):335-7 - PubMed
  30. Eur J Cell Biol. 1997 May;73(1):40-8 - PubMed
  31. J Biol Chem. 1986 Mar 25;261(9):4324-7 - PubMed
  32. J Biol Chem. 1983 Feb 25;258(4):2072-5 - PubMed
  33. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2970-4 - PubMed
  34. Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4830-5 - PubMed
  35. ACS Infect Dis. 2020 Apr 10;6(4):588-602 - PubMed
  36. Pathog Dis. 2018 Mar 1;76(2): - PubMed
  37. Sci Rep. 2021 Mar 8;11(1):5429 - PubMed
  38. Infect Immun. 1989 Nov;57(11):3324-30 - PubMed
  39. Toxins (Basel). 2019 Jun 27;11(7): - PubMed
  40. Proc Natl Acad Sci U S A. 1982 May;79(10):3129-33 - PubMed
  41. J Clin Invest. 2005 Dec;115(12):3594-601 - PubMed
  42. Infect Immun. 1995 Mar;63(3):825-32 - PubMed
  43. Clin Microbiol Rev. 2016 Jul;29(3):449-86 - PubMed
  44. Pathog Dis. 2015 Nov;73(8):ftv073 - PubMed
  45. Pathog Dis. 2015 Dec;73(9):ftv081 - PubMed

Publication Types

Grant support